Skip to content

Matias Trillini

  • Mario Negri Institute for Pharmacological Research
  • 8h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 5075CitationsNumber of citations received by Matias's publications. Updated daily.

Other IDs

Co-authors (1292)

Publications (5)

  • Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): A randomised, double-blind, placebo-controlled, crossover trial

    • Parvanova A
    • Trillini M
    • Podestà M
    • et al.
    N/AReaders
    0Citations
    Get full text
  • Renal and systemic effects of calorie restriction in patients with type 2 diabetes with abdominal obesity: A randomized controlled trial

    • Ruggenenti P
    • Abbate M
    • Ruggiero B
    • et al.
    N/AReaders
    2Citations
    Get full text
  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

    • Forouzanfar M
    • Alexander L
    • Anderson H
    • et al.
    N/AReaders
    625Citations
    Get full text
  • Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

    • Vos T
    • Barber R
    • Bell B
    • et al.
    N/AReaders
    1,358Citations
    Get full text
  • Chronic kidney disease and risk of mortality, cardiovascular events or end-stage renal disease in older patients with hypertension

    • Gentile G
    • Trillini M
    N/AReaders
    N/ACitations
    Get full text

Professional experience

Istituto Di Ricerche Farmacologiche Mario Negri